Clinical pathways in china – an evaluation

International Journal of Health Care Quality Assurance

Volumn 28, Issue 4, 2015, Pages 394-411

  He, Jingwei Alex ^a   Yang, Wei ^b  

^a THE EDUCATION UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Care quality; China; Clinical pathways; Cost containment

Indexed keywords

CHINA; CLINICAL PATHWAY; COST CONTROL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; HUMAN; INTERVIEW; LENGTH OF STAY; MEDICAL STAFF; PILOT STUDY; STATISTICS AND NUMERICAL DATA;

CHINA; COST CONTROL; CRITICAL PATHWAYS; HEALTH CARE REFORM; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; INTERVIEWS AS TOPIC; LENGTH OF STAY; MEDICAL STAFF, HOSPITAL; PILOT PROJECTS; QUALITY INDICATORS, HEALTH CARE;

EID: 84924248113     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/IJHCQA-09-2014-0096     Document Type: Article

References (46)

1. Blumenthal, D. and Hsiao, W. (2005), “Privatization and its discontents: the evolving Chinese health care system”, The New England Journal of Medicine, Vol. 353 No. 11 pp. 1165-1170
2. Chen, W., Ji, G., Pu, F. and Hao, H. (2013), “The impact of clinical pathways on hospitalization days and costs of five diseases”, China Medical Archives, Vol. 14 No. 7, pp. 23-25
3. Choong, P.F., Langford, A.K., Dowsey, M.M. and Santamaria, N.M. (2000), “Clinical pathway for fractured neck of femur: a prospective, controlled study”, Medical Journal of Australia, Vol. 173 No. 9, pp. 423-426
4. De Bleser, L., Depreitere, R., De Waele, K., Vanhaecht, K., Vlayen, J. and Sermeus, W. (2006), “Defining pathways”, Journal of Nursing Management, Vol. 14 No. 7, pp. 553-563
5. Deng, Y., Jiao, Y. and Zhao, X. (2013), “Progress and evaluation on stroke clinical pathways”, China Modern Medicine, Vol. 20 No. 33, pp. 14-19
6. Dowsey, M.M., Kilgour, M.L., Santamaria, N.M. and Choong, P.F. (1999), “Clinical pathway in hip and knee arthroplasty: a prospective randomized controlled study”, Medical Journal of Australia, Vol. 170 No. 2, pp. 59-62
7. Feagan, B.G. (2000), “A controlled trial of a critical pathway for treatment of community-acquired pneumonia”, Journal of American Medical Association, Vol. 283 No. 6, pp. 749-755
8. Gao, J., Tang, S., Tolhurst, R. and Rao, K. (2001), “Changing access to health services in urban China: implications for equity”, Health Policy and Planning, Vol. 16 No. 3, pp. 302-312
9. Gao, X., Zheng, C., Jiang, Y., Qi, J., Liu, L. and Sun, S. (2010), “The study and practice of clinical pathway in the treatment of inguinal hernia”, China Journal of Hernia Abdominal Wall Surgery, Vol. 4 No. 3, pp. 306-310
10. Gravelle, H., Morris, S. and Sutton, M. (2006), “Economic studies of equity in the consumption of health care”, in: Jones, A.M. (Ed.), The Elgar Companion to Health Economics, Edward Elgar, Cheltenham, pp. 193-204
11. Gu, E. (2001), “Market transition and the transformation of the health care system in urban China”, Policy Studies, Vol. 22 Nos 3/4 pp. 197-215
12. He, J. (2011), “China’s ongoing public hospital reform: initiatives, constraints and prospect”, Journal of Asian Public Policy, Vol. 4 No. 3, pp. 342-349
13. He, J. and Qian, J. (2013), “Hospitals’ responses to administrative cost-containment policy in urban China: the case of Fujian province”, The China Quarterly, Vol. 216, pp. 946-969
14. Hernandez-Quevedo, C. and Jimenez Rubio, D. (2009), “Socioeconomic differences in health between the Spanish and immigrant population: evidence from the national health survey”, Gac Sanit, Vol. 23 No. 1, pp. 47-52
15. Hindle, D. and Yazbeck, A.M. (2005), “Clinical pathways in 17 European union countries: a purposive survey”, Australian Health Review, Vol. 29 No. 1, pp. 94-104
16. Hsiao, W. (1995), “The Chinese health care system: lessons for other nations”, Social Science and Medicine, Vol. 41 No. 8, pp. 1047-1055
17. Ji, Y., Luo, W. and Chu, J. (2005), “Difficulties associated with the implementation of clinical pathways”, Chinese Health Quality Management, Vol. 12 No. 5, pp. 20-21
18. Jiao, Y., Hu, R. and Zhao, M. (2013), “The impact of clinical pathways on quality management and control”, China Health Insurance, Vol. 7 No. 2, pp. 24-27
19. Johnson, K.B., Blaisdell, C.J., Walker, A. and Eggleston, P. (2000), “Effectiveness of a clinical pathway for inpatient asthma management”, Pediatrics, Vol. 106 No. 5, pp. 1006-1012
20. Jones, A.M. (2007), Applied Econometrics for Health Economists: A Practical Guide, Radcliffe Publishing, York.
21. Kim, M.H., Morady, F., Conlon, B., Kronick, S., Lowell, M. and Bruckman, D. (2002), “A prospective, randomized, controlled trial of an emergency department-based atrial fibrillation treatment strategy with low-molecular-weight heparin”, Annuals of Emergency Medicine, Vol. 40 No. 2, pp. 187-192
22. Lang, L., Ge, X., Yang, X., Shi, W., Zhang, Y., Zhang, Z., Wei, Y., Zhang, L., Huang, Y. and Shen, J. (2010), “Application of clinical pathway in perioperative care of patients with intracranial aneurysms”, Chinese Journal of Nursing, Vol. 45 No. 8, pp. 684-686
23. Li, S. and Fu, X. (2014), “Analysis on the clinical pathway for patients with cataract”, International Eye Sciences, Vol. 14 No. 2, pp. 343-345
24. Liu, N., Pan, T., Du, Y., Cheng, Y. and Guo, Y. (2012), “Implementation and evaluation of clinical pathway for type I diabetes”, Chinese General Practice, Vol. 15 No. 11, pp. 3700-3703
25. Liu, X. and Mills, A. (2003), “The influence of bonus payments to doctors on hospital revenue: results of a quasi-experimental study”, Applied Health Economics and Health Policy, Vol. 2 No. 2, pp. 91-98
26. Liu, X., Liu, Y. and Chen, N. (2000), “The Chinese experience of hospital price regulation”, sHealth Policy and Planning, Vol. 15 No. 2, pp. 157-163
27. Luo, X. (2011), “The transplanting of the moral risk precaution into rural cooperating medical system: a case on the introduction and practice of ration charge mode by per person in Panyu”, The Journal of Gansu Administration Institute, Vol. 11 No. 6, pp. 71-77
28. Ma, G., Cai, X., Meng, Y., Zhang, D., Tang, S., Liu, X., Bao, Y., Chen, Y. and Bai, Y. (2013), “The effects of clinical pathways on 23 diseases”, Chinese Journal of Hospital Administration, Vol. 29 No. 5, pp. 353-356
29. Ma, J., Lu, M. and Quan, H. (2008), “From a national, centrally planned health system to a system based on market: lessons from China”, Health Affairs, Vol. 27 No. 4, pp. 937-947
30. Ministry of Health (2012), “Guidance on undertaking the clinical pathway management in the twelfth Five-Year Plan”, available at: www.moh.gov.cn/mohyzs/s3586/201210/56150.shtml (accessed June 20, 2014).
31. Ministry of Health (2013), “Notice on the implementation of the clinical pathway management”, available at: www.moh.gov.cn/yzygj/s7652/201309/b5484320ef824420ac33439508bb dcc5.shtml (accessed June 24, 2014).
32. O’Donnell, O., Van Doorslaer, E., Wagstaff, A. and Lindelow, M. (2008), Analyzing Health Equity using Household Survey Data: a Guide to Techniques and their Implementation, World Bank, Washington DC.
33. Queensland Health Clinical Pathways Board. (2002), “Clinical pathways: definition”, available at: http://www.health.qld.gov.au/caru/pathways/ (accessed June 21, 2014).
34. Rotter, T., Kinsman, L., James, E.L., Machotta, A., Gothe, H., Willis, J., Snow, P. and Kugler, J. (2010), Clinical Pathways: Effects on Professional Practice, Patient Outcomes, Length of Stay and Hospital Costs (Review), Wiley & Son, Hoboken, NJ.
35. Saint, S., Hofer, T.P., Rose, J.S., Kaufman, S.R. and McMahon, L.F. (2003), “Use of critical pathways to improve efficiency: a cautionary tale”, American Journal of Managed Care, Vol. 9 No. 11, pp. 758-765
36. Wang, J. and Gong, D. (2013), “Evaluation of clinical pathway for transient ischemic attack”, Chinese Journal of Clinical Research, Vol. 26 No. 4, pp. 341-342
37. Wang, K., Peng, D. and Lin, J. (2013a), “The clinical pathway for total knee replacement and its effects on hospitalization costs”, Chinese Health Economics, Vol. 32 No. 11, pp. 30-32
38. Wang, M. and Lin, K. (2012), “The effects of clinical pathways on hospitalization days and expenditures”, Health Economics Research, Vol. 296 No. 1, pp. 46-48
39. Wang, Y., Li, L., Mo, Y. and Lu, R. (2013b), “The design and application of clinical pathway systems”, Journal of Medical Informatics, Vol. 34 No. 10, pp. 24-27
40. Xu, X., Chen, T., Dou, J. and Wu, M. (2012), “An impact assessment of clinical pathways”, China Medical Archives, Vol. 13 No. 5, pp. 54-55
41. Yang, W. and Wu, X. (2014), “Paying for outpatient care in rural China: cost escalation under China’s new co-operative medical scheme”, Health Policy and Planning, doi:10.1093/heapol/ czt111
42. Yip, W. and Hsiao, W. (2008), “The Chinese health system at a crossroads”, Health Affairs, Vol. 27 No. 2, pp. 460-468
43. Zeng, Y., Wang, J., Zhang, C., Chen, L., Liao, S. and Yu, Q. (2013), “An evaluation and analysis on the implementation of clinical pathways”, Chinese Hospital Management, Vol. 33 No. 11, pp. 27-28
44. Zhang, W. and Dong, Y. (2014), “An evaluation on the implementation of clinical pathway for capillary bronchitis”, Guide of China Medicine, Vol. 12 No. 5, pp. 27-28
45. Zhao, K., Zhang, Y., Ma, L., Sui, Y., Qi, X. and Liu, J. (2013), “Progress and outcomes of clinical pathway pilot in public hospitals”, China Health Economics, Vol. 32 No. 1, pp. 76-80
46. Zhong, J. (2001), “Influencing factors on medical quality and measures for management”, Chinese Journal of Hospital Management, Vol. 17 No. 9, pp. 536-548.